Clinical trials: Rhesus D Genotype
Rhesus D Genotype
A Noninvasive Test for Fetal RHD Genotype
The objective of this study is to evaluate the performance of Sequenom's noninvasive test for fetal RHD genotype. The test uses MALDI-TOF mass spectrometry to detect DNA.
- Trial name
- NAFTnet RHD (NCT00871195)
- Where
- 13 sites in United States, Canada
- Volunteers
- 520 people
- Sponsor
- Sequenom, Inc.
Rhesus D Genotype
Evaluation of a Noninvasive Fetal RHD Genotyping Test
This study will collect whole blood samples from pregnant subjects who are RhD negative by serology to develop an assay for RHD determination of the fetus.
- Trial name
- IRIS (NCT01054716)
- Where
- 5 sites in United States
- Volunteers
- 500 people
- Sponsor
- Sequenom, Inc.
Rhesus D Genotype, Pregnancy
Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women
The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood…
- Trial name
- NCT06690099
- Where
- United States
- Volunteers
- 500 people
- Sponsor
- Devyser Inc.